News
Abridge closes $300M in series E funding, hits $5.3B valuation
Abridge, which provides ambient listening technology for clinical documentation to more than 150 health systems, has raised $300 million to bring its valuation to $5.3 billion. The series E funding round led by venture capital firm Andreessen Horowitz will allow Abridge to build new products,
In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B
Abridge nabbed a $300 million Series E led by a16z, months after it closed its previous $250 million fundraise. The 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market,
Abridge, a startup that offers an AI notetaking tool for doctors, raised a $300 million Series E led by a16z at a $5.3 ...
Health systems and medical practices are increasingly turning to ambient AI technology to help with burdensome medical ...
When you sit down with Abridge Founder and CEO Shiv Rao, MD, you might expect the high-octane energy of a tech entrepreneur — the fast-talking, restless ambition behind a fast-growing startup.
Abridge CEO says ‘hypergrowth’ is why it’s moving to hire in San Francisco, sparking talent debate in Pittsburgh ecosystem The medtech AI startup can’t properly staff up in only its hometown, ...
Abridge expanded its generative AI tools for medical documentation into the inpatient setting, the company announced ...
Athenahealth will offer Abridge's artificial intelligence scribing tool to its ... "It'll be incumbent upon us to make sure that we're able to demonstrate differentiation," Abridge CEO Dr. Shiv ...
The deployment is one of Abridge’s largest health system partnerships, said CEO Shiv Rao. The product will be available to 4,000 employed physicians and advanced practice providers.
Athenahealth will offer Abridge’s artificial intelligence scribing tool to its network of more than 160,000 clinicians.
Athenahealth will offer Abridge’s artificial intelligence scribing tool to its network of more than ... there are going to be winners and losers over time," Athenahealth CEO Bob Segert told ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback